Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adjuvant therapy in breast cancer and venous thromboembolism.

Thrombosis research - 1 Oct 2012

Mandalà Mario, Tondini Carlo

Abstract excerpt

Breast cancer patients are considered to be at relatively low risk of developing a TEE. The highest incidence of VTE events occurs in metastatic breast cancer patients likely due to extension of disease, immobility for pathologic bone fractures, cancer cachexia and venous compression by the tumour mass. Although thrombosis is less common in patients with early stage cancer compared to those with more advanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Chemotherapy, Adjuvant
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinolytic Agents

Share to Incidence

Share to Point Mutation

Share to Risk Assessment

Share to Venous Thromboembolism

Source

Identifiers

PMID: 23026668
DOI: 10.1016/j.thromres.2012.08.280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adjuvant therapy in breast cancer and venous thromboembolism.PMID 23026668Read ↗

Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.Semantic proximity Read ↗

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.Semantic proximity Read ↗

Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.Semantic proximity Read ↗

Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.Semantic proximity Read ↗

Cancer-associated thrombosis in the era of precision oncology: Mechanisms, challenges and future directions.Semantic proximity Read ↗

Incidence and Risk Factors for Postoperative Venous Thromboembolism in Patients with Endometrial Cancer: Systematic Review and Meta-analysisSemantic proximity Read ↗

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.Semantic proximity Read ↗

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.Semantic proximity Read ↗

Association between adjuvant chemotherapy and cancer-associated venous thromboembolism in patients with colorectal cancerSemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Risk factors for thrombosis in cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.